Search

Displaying results 4851 - 4860 of 6198 in total
  1. Drug

    Denibulin

    go.drugbank.com/drugs/DB05932
    Experimental

    Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.

  2. Drug

    GA31

    go.drugbank.com/drugs/DB32871
    Experimental

    GA31 is an 31-amino acid TREM-1 inhibitory peptide.

  3. Drug

    LY-2183240

    go.drugbank.com/drugs/DB17035
    Experimental

    LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037]

  4. Drug

    Tamrintamab pamozirine

    go.drugbank.com/drugs/DB17222
    Investigational

    Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.

  5. Drug

    UX053

    go.drugbank.com/drugs/DB18558
    Investigational

    UX053 is an mRNA encoding the human glycogen debranching enzyme.

  6. Drug

    BMS-488043

    go.drugbank.com/drugs/DB05532
    Experimental

    BMS-488043 has been investigated as an anti-HIV agent.

  7. Drug

    R-95845

    go.drugbank.com/drugs/DB07327
    Experimental

    R-95845 is an inhibitor of HIV-1 reverse transcriptase.

  8. Drug

    Bufexamac

    go.drugbank.com/drugs/DB13346
    ApprovedWithdrawn

    Bufexamac was also withdrawn by the EMA in April 2010.

  9. Drug

    VGA039

    go.drugbank.com/drugs/DB18385
    Investigational

    VGA039 is an IgG4 monoclonal antibody directed against protein S.

  10. Drug

    Aminomethylbenzoic acid

    go.drugbank.com/drugs/DB13244
    Experimental

    Aminomethylbenzoic acid may be useful as an antifibrinolytic agent [A174994].